Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Join us in reshaping the landscape of patient care, one custom formulation at a time.
The following steps reflect general best practice for subcutaneous self-injection, consistent with Royal College of Nursing (RCN) guidance and NHS patient-facing advice for similar injectable medicines
Our team offers personalized guidance to help you navigate postpartum challenges, including weight management and medication decisions
On 1 April 2026, the FDA approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical conditions, making it the first small-molecule oral GLP-1 receptor agonist to receive regulatory clearance anywhere in the world
US$ 29.12
US$ 25.96
US$ 29.50
US$ 22.68
US$ 21.23
US$ 27.23
US$ 28.88
US$ 25.52
